JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2020, 69(1):43-47 | DOI: 10.36290/csf.2020.005

Investigation of thioctic acid, magnesium stearate and pyridoxine hydrochloride compatibility

Maksym Almakaiev1,*, Olga Vashchenko2, Dmitry Sofronov3, Liliia Budianska2, Longin Lisetski2
1 National University of Pharmacy, Kharkiv, Ukraine
2 Institute for Scintillation Materials of NAS of Ukraine, Kharkiv, Ukraine
3 State Scientific Institution «Institute for Single Crystals», NAS of Ukraine, Kharkiv, Ukraine

To identify possible interactions of components in dosage forms, studies are usually carried out at the stage of pharmaceutical development. Such studies can predict compatibility of active pharmaceutical ingredients and excipients in order to optimize drug formulation and certain parameters of technological process. Compatibility of some components of a newly developed neuroprotective medicinal product 'Neuronucleos', namely, thioctic acid, pyridoxine hydrochloride, magnesium stearate and magnesium lactate, was studied by means of differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR). No interactions were observed between thioctic acid and pyridoxine hydrochloride. Formation of an intermolecular complex between thioctic acid and magnesium stearate was established, in which this acid substitutes the crystalline water of magnesium stearate. No significant interactions were found for magnesium lactate with thioctic acid or magnesium stearate. Thus, pharmaceutical compatibility of the most of the tested 'Neuronucleos' components was studied and established, with the only exception (thioctic acid with magnesium stearate). Moreover, the present study provides valuable information about thermal effects in a certain temperature range, which is important for setting the technological process parameters.

Keywords: pharmaceutical compatibility; thioctic acid; pyridoxine hydrochloride; magnesium stearate; differential scanning calorimetry; IR-spectroscopy

Received: October 7, 2019; Accepted: January 15, 2020; Published: January 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Almakaiev M, Vashchenko O, Sofronov D, Budianska L, Lisetski L. Investigation of thioctic acid, magnesium stearate and pyridoxine hydrochloride compatibility. Čes. slov. farm. 2020;69(1):43-47. doi: 10.36290/csf.2020.005.
Download citation

References

  1. Bharate S. S., Bharate S. B., Bajaj A. N. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients - a comprehensive review. J. Excipients and Food Chem. 2010; 1(3), 3-27.
  2. Serajuddin A. T. M., Thakur A. B., Ghoshal R. N., Fakes M. G., Ranadive S. A., Morris K. R., Varia S. A. Selection of Solid dosage form composition through drug-excipient compatibility testing. J. Pharmaceut. Sci. 1999; 88(7), 696-704. Go to original source... Go to PubMed...
  3. Електронний ресурс: https://pubchem.ncbi.nlm.nih.gov/compound/6112.
  4. Delaney S. P., Nethercott M. J., Mays C. J., Winquist N. T., Arthur D., Calahan J. L., Sethi M., Pardue D. S., Kim J., Amidon G., Munson E. J. Characterization of synthesized and commercial forms of magnesium stearate using differential scanning calorimetry, thermogravimetric analysis, powder X-ray diffraction, and solid-state NMR spectroscopy. J. Pharmaceut. Sci. 2017; 106(1), 338-347. Go to original source... Go to PubMed...
  5. Li J., Wu Y. Lubricants in pharmaceutical solid dosage forms. Lubricants 2014; 2, 21. Go to original source...
  6. da Silva E. P., Pereira M. A. V., de Barros Lima I. P., Barros Lima N. G. P., Barbosa E. G., Soares Aragão C. F., Barreto Gomes A. P. Compatibility study between atorvastatin and excipients using DSC and FTIR. J. Therm. Anal. Calorim. 2016; 123(2), 933-939. doi:10.1007/s10973-015-5077-z Go to original source...
  7. Fernandes F. H. A., de Almeida V. E., de Medeiros F. D., da Silva P. C. D, da Simões M. O. S., Veras G., Medeiros A. C. D. Evaluation of compatibility between Schinopsis brasiliensis Engler extract and pharmaceutical excipients using analytical techniques associated with chemometric tools. J. Therm. Anal. Calorim. 2016; 123(3), 2531-2542. doi:10.1007/s10973-016-5241-0 Go to original source...
  8. Santana C. P., Fernandes F. H. A., Brandão D. O., da Silva P. C. D., Correia L. P., Nóbrega F. P., de Medeiros F. D., Diniz P. H. G. D., Véras G., Medeiros A. C. D. Compatibility study of dry extract of Ximenia americana L. and pharmaceutical excipients used in solid state. J. Therm. Anal. Calorim. 2018; 133(1), 603-617. doi:10.1007/s10973-017-6764-8 Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.